Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation.
Nature communications
View this publicationNature communications
View this publicationAmerican journal of medical genetics. Part A
View this publicationCell host & microbe
View this publicationAntioxidants (Basel, Switzerland)
View this publicationPublication categories: Top publication
Nature biotechnology
View this publicationFrontiers in chemistry
View this publicationEuropean journal of medicinal chemistry
View this publicationNature chemical biology
View this publicationNature chemical biology
View this publicationScience (New York, N.Y.)
View this publication